Blausiegel Industry and Trade

Blau Farmacêutica, formerly known as Blausiegel, is a leading Brazilian pharmaceutical company specializing in high-complexity medicines for the institutional and hospital sectors. The company focuses on therapeutic areas such as oncology, nephrology, hematology, and infectious diseases, with a strong emphasis on biotechnology and biosimilars. Blau operates several state-of-the-art manufacturing facilities in Brazil and has established a significant commercial presence across Latin America through its subsidiaries. As a publicly traded entity on the B3 exchange, the company continues to invest in R&D to expand its portfolio of biologics and specialized injectables. Its vertically integrated business model includes internal production of active pharmaceutical ingredients and finished dosage forms.